Description
Copaxone Pre-Filled Syr (glatiramer acetate) is a neurology medications agent listed in our Neurology medications directory and prescribed for multiple sclerosis (2.1). Administered via the subcutaneous route, Copaxone Pre-Filled Syr is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Copaxone Pre-Filled Syr is a medication containing the active pharmaceutical ingredient glatiramer acetate, classified pharmacologically as a neurology medications agent (2.1). It is clinically indicated for the management of multiple sclerosis as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Neurology medications section of our catalogue, patients and prescribers frequently review Copaxone Pre-Filled Syr alongside related therapies such as Ajovy (Fremanezumab), Imigran (Sumatriptan Succinate), Imitrex (Sumatriptan), and Plegridy Admin Pack (Peginterferon beta-1a).
Official Indications and Usage
Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. (2.1)
Mechanism of Action and Pharmacology
The mechanism(s) by which glatiramer acetate exerts its effects in patients with MS are not fully understood. However, glatiramer acetate is thought to act by modifying immune processes that are believed to be responsible for the pathogenesis of MS. This hypothesis is supported by findings of studies that have been carried out to explore the pathogenesis of experimental autoimmune encephalomyelitis, a condition induced in animals through immunization against central nervous system derived material containing myelin and often used as an experimental animal model of MS. Studies in animals and in vitro systems suggest that upon its administration, glatiramer acetate-specific suppressor T-cells are induced and activated in the periphery. (2.1)
What is Multiple sclerosis?
Multiple sclerosis affects the central nervous system. Treatments may address disease activity, relapses, or particular symptoms. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Multiple sclerosis condition guide for appointment questions and related therapies (2.1).
Ordering Copaxone Pre-Filled Syr from Canada for U.S. Delivery
U.S. patients can order Copaxone Pre-Filled Syr (Glatiramer) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax 1-888-804-1287.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$29.99 USD Cold-Chain Cooler
- Packed in an insulated thermal cooler with gel packs and temperature indicators for $29.99 USD.
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Copaxone Pre-Filled Syr |
| Chemical / Generic Name | Glatiramer Acetate |
| Pharmacological Class | Neurology medications agent |
| Therapeutic Category | Neurology medications |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Subcutaneous |
| Dosage Forms & Strengths | Injection: 20 mg per mL in a single-dose, prefilled syringe with a white plunger. For subcutaneous use only |
| Primary Indications | Multiple Sclerosis |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | 5M691HL4BO |
| NLM RxNorm Concept ID (RxCUI) | 1487361 |
| FDA Application License | ANDA214022 |
| Official DailyMed SetID | 1ec10223-880d-402f-a759-9cd179bf09de |
| Catalogue Index Links | Letter C Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
For subcutaneous injection only; doses are not interchangeable Glatiramer acetate injection 20 mg/mL per day Glatiramer acetate injection 40 mg/mL three times per week Before use, allow the solution to warm to room temperature. (2.1)
Presentations and Strengths
- Injection: 20 mg per mL in a single-dose, prefilled syringe with a white plunger. For subcutaneous use only. (2.1)
Administration Guidance
Copaxone Pre-Filled Syr is administered by injection according to your prescriber’s individualized dosing schedule (2.1). Always verify the concentration, pen or vial presentation, and dose markings prior to administration, rotate injection sites as instructed, and never share injection pens, needles, or cartridges between patients.
Missed Dose Guidance
If you miss a scheduled dose of Copaxone Pre-Filled Syr, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Copaxone Pre-Filled Syr is glatiramer acetate (2.1).
Inactive Ingredients (Excipients)
According to the U.S. FDA product labeling, formulation excipients include 40 mg of mannitol (2.1). Inactive ingredients can vary slightly between different manufacturers and international or generic presentations; review the dispensed carton if you have known excipient sensitivities.
Cautions and important safety information
Boxed Warning
Warning: anaphylactic reactions Cases of life-threatening and fatal anaphylaxis have been reported with glatiramer acetate injection. Anaphylaxis can occur at any time following initiation of therapy, from as early as after the first dose, up to years following initiation of therapy. Make patients aware of the symptoms of anaphylaxis, which may overlap with those of an immediate post-injection reaction; instruct them to seek immediate medical care should these symptoms occur. Prompt identification of anaphylaxis is important to avoid a delay in treatment. Glatiramer acetate injection is contraindicated in patients with a history of hypersensitivity reactions to glatiramer acetate injection, including anaphylaxis. (2.1)
Contraindications
Glatiramer acetate injection is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol. Reactions have included anaphylaxis. (2.1)
Key Clinical Precautions
Before starting or continuing Copaxone Pre-Filled Syr, discuss your complete medical history with your healthcare provider. Key clinical cautions include (2.1):
- Hepatic (liver) effects: Elevations in liver enzymes or rare cases of severe hepatic injury have been reported. Baseline and periodic liver function tests may be recommended; seek medical evaluation for jaundice, dark urine, or persistent right-upper-abdominal pain.
- Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
Pregnancy, Lactation, and Special Populations
Available data from pharmacovigilance and published observational studies over decades of use with glatiramer acetate during pregnancy have not identified a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Administration of glatiramer acetate by subcutaneous injection to pregnant rats and rabbits resulted in no adverse effects on embryofetal or offspring development. The background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other outcomes. (2.1)
Interactions
Always provide your prescribing physician and pharmacist with an up-to-date list of all prescription medications, over-the-counter products, vitamins, and herbal supplements you take before starting Copaxone Pre-Filled Syr (2.1).
Side effects
Like all medications, Copaxone Pre-Filled Syr can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (2.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Xerostomia (dry mouth): Sipping water or using sugar-free lozenges can help relieve oral dryness.
- Skin rash: Mild skin eruptions can occur; seek immediate care if a rash blisters, peels, or is accompanied by fever.
- Pruritus (mild itching): Report any spreading rash, hives, or mucosal irritation to your healthcare provider.
- Peripheral edema (swelling of ankles, feet, or hands): Fluid retention may occur; notify your doctor if swelling is rapid or accompanied by shortness of breath.
Clinical Trial and Postmarketing Adverse Reactions
The following serious adverse reactions are described elsewhere in the labeling (2.1):
- Anaphylactic Reactions.
- Immediate Post-Injection Reaction.
- Chest Pain.
- Lipoatrophy and Skin Necrosis.
- Potential Effects on Immune Response.
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Glatiramer acetate injection is a clear, colorless to slightly yellow, sterile, nonpyrogenic solution supplied as: 20 mg per mL in a single-dose, prefilled syringe with a white plunger, in individual blister packages supplied in 30-count cartons (NDC 82983-429-30). Some glatiramer acetate products can be administered by an optional compatible autoinjector. Compatible autoinjectors are supplied separately if available, but the availability of compatible autoinjectors may change with time. Store glatiramer acetate injection refrigerated at 2°C to 8°C (36°F to 46°F). (2.1)
Store Copaxone Pre-Filled Syr in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (2.1).
Frequently Asked Questions About Copaxone Pre-Filled Syr
What is Copaxone Pre-Filled Syr and what active ingredient does it contain?
Copaxone Pre-Filled Syr is a neurology medications agent containing the active pharmaceutical ingredient glatiramer acetate. It is supplied for subcutaneous administration and requires a valid prescription where applicable.
How does Copaxone Pre-Filled Syr work in the body?
The mechanism(s) by which glatiramer acetate exerts its effects in patients with MS are not fully understood. However, glatiramer acetate is thought to act by modifying immune processes that are believed to be responsible for the pathogenesis of MS. This hypothesis is supported by findings of studies that have been carried out to explore the pathogenesis of experimental autoimmune encephalomyelitis, a condition induced in animals through immunization against central nervous system derived material containing myelin and often used as an experimental animal model of MS.
What conditions is Copaxone Pre-Filled Syr prescribed to treat?
Copaxone Pre-Filled Syr is primarily indicated for multiple sclerosis. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Copaxone Pre-Filled Syr?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Copaxone Pre-Filled Syr is administered via the subcutaneous route. Take or apply it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Copaxone Pre-Filled Syr?
Commonly reported side effects of Copaxone Pre-Filled Syr include feeling sick, vomiting, dry mouth, rash, itching, and swelling. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Copaxone Pre-Filled Syr?
Share your full list of current prescription medications, over-the-counter products, and supplements with your prescriber and pharmacist so they can screen for any potential drug interactions.
Can Copaxone Pre-Filled Syr be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Copaxone Pre-Filled Syr to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Copaxone Pre-Filled Syr online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Copaxone Pre-Filled Syr (Glatiramer) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Copaxone Pre-Filled Syr have a generic equivalent (Glatiramer) at a Canada pharmacy?
Currently, Copaxone Pre-Filled Syr (Glatiramer) is dispensed in our catalogue as a brand-name formulation. Check our Glatiramer active ingredient hub for updates as licensed generic presentations become available.
How is Copaxone Pre-Filled Syr shipped to U.S. residents, and how much does shipping cost?
Copaxone Pre-Filled Syr requires Cold-Chain temperature-sensitive handling at a flat rate of $29.99 USD per order. Once your prescription passes safety checks (<1 business day) and you complete the mandatory licensed pharmacist consultation (check your voicemails and text messages), Copaxone Pre-Filled Syr is packed in a medication-specific insulated thermal cooler with cold gel packs, seasonal packaging adjustments, and temperature indicators, and shipped from Manitoba, Canada via Canada Post and USPS (3 to 7 business days) with full tracking. A physical U.S. street address (no P.O. Boxes) and signature upon delivery are required.
How can I send or transfer my Copaxone Pre-Filled Syr prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Copaxone Pre-Filled Syr prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to 1-888-804-1287. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Copaxone Pre-Filled Syr (Glatiramer Acetate) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Glatiramer Acetate. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: Multiple Sclerosis. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (3.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
